Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Adaptive Biotechnologies Corp (ADPT)
|
|
| Segments |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 |
| | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues |
| Sequencing Revenue | 78.9 | 41.4 | 43.5 | 33.0 | 22.8 |
| Development Revenue | 75.4 | 56.9 | 41.6 | 22.7 | 15.7 |
| Development Support Revenue | 65.4 | 54.4 | 39.6 | 12.7 | 15.7 |
| Development Revenue Regulatory Milestones | 10.0 | 2.5 | 2.0 | 10.0 | |
| |
| Mix |
| Sequencing Revenue | 51.1% | 42.1% | 51.2% | 59.2% | 59.2% |
| Development Revenue | 48.9% | 57.9% | 48.8% | 40.8% | 40.8% |
| Development Support Revenue | 42.4% | 55.3% | 46.5% | 22.8% | 40.8% |
| Development Revenue Regulatory Milestones | 6.5% | 2.5% | 2.4% | 18.0% | |
| |
| Growth |
| Sequencing Revenue | 90.4% | -4.8% | 32.0% | 44.9% | |
| Development Revenue | 32.5% | 37.0% | 83.2% | 44.6% | |
| Development Support Revenue | 20.2% | 37.6% | 211.8% | -19.1% | |
| Development Revenue Regulatory Milestones | 300.0% | 25.0% | -80.0% | | |
|